|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.400 USD | -3.61% |
|
+17.65% | -72.88% |
| 06-29 | Atossa Therapeutics, Inc.(NasdaqCM:ATOS) added to Russell Microcap Value Benchmark Index | CI |
| 06-29 | Atossa Therapeutics, Inc.(NasdaqCM:ATOS) added to Russell 3000E Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 21.44M | - | - | - | - | - |
| 49.74B | |||||
| 40.49B | - | - | - | - | - |
| 34.35B | |||||
| 34.75B | |||||
| 26.98B |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
